Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer

被引：28
|
作者：
Tamez, S. [1 ]
Norizoe, C. [1 ]
Ochiai, K. [2 ]
Takahashi, D. [1 ]
Shimojima, A. [1 ]
Tsutsumi, Y. [1 ]
Yanaihara, N. [2 ]
Tanaka, T. [2 ]
Okamoto, A. [2 ]
Urashima, M. [1 ,3 ]
机构：
[1] Jikei Univ, Sch Med, Div Mol Epidemiol, Minato Ku, Tokyo 1058461, Japan
[2] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1058461, Japan
[3] Jikei Univ, Sch Med, Dept Pediat, Tokyo 1058461, Japan
来源：
BRITISH JOURNAL OF CANCER | 2009年 / 101卷 / 12期
关键词：
prognosis; single nuclear polymorphisms; SNPs; biomarker; CIRCULATING 25-HYDROXYVITAMIN-D LEVELS; ULTRAVIOLET-B IRRADIANCE; BONE-MINERAL DENSITY; CELL LUNG-CANCER; GENE POLYMORPHISMS; SURVIVAL; RISK; WOMEN;
D O I：
10.1038/sj.bjc.6605414
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
BACKGROUND: Recently, the vitamin D receptor (VDR) polymorphism FokI was shown to be associated with susceptibility to ovarian cancer. We aimed to examine whether VDR FokI polymorphisms influence the survivals of patients with epithelial ovarian cancer (EOC). METHODS: VDR polymorphisms from FokI in 101 patients with EOC were genotyped by sequencing. Overall survival was compared between FokI single nucleotide polymorphism using Kaplan-Meier survival curves with log-rank tests and the Cox proportional hazard model adjusted for ages, stages, histology, and existence of residual tumour. RESULTS: The FokI C/C genotypes were associated with better prognosis compared with the C/T and T/T genotypes (log-rank test: P = 0.008; adjusted hazard ratio, 0.18; 95% CI 0.05-0.61; P = 0.006). CONCLUSIONS: These results suggest that the VDR polymorphisms from the FokI genotype may be associated with improved prognosis of patients with EOC. British Journal of Cancer (2009) 101, 1957-1960. doi: 10.1038/sj.bjc.6605414 www.bjcancer.com Published online 10 November 2009 (C) 2009 Cancer Research UK
引用
收藏
页码：1957 / 1960
页数：4
相关论文
共 50 条
  • [1] Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer
    S Tamez
    C Norizoe
    K Ochiai
    D Takahashi
    A Shimojima
    Y Tsutsumi
    N Yanaihara
    T Tanaka
    A Okamoto
    M Urashima
    British Journal of Cancer, 2009, 101 : 1957 - 1960
  • [2] Polymorphisms in the Vitamin D Receptor and Risk of Ovarian Cancer in Four Studies
    Tworoger, Shelley S.
    Gate, Margaret A.
    Lee, I-Min
    Buring, Julie E.
    Titus-Ernstoff, Linda
    Cramer, Daniel
    Hankinson, Susan E.
    CANCER RESEARCH, 2009, 69 (05) : 1885 - 1891
  • [3] Vitamin D Exposure and Ovarian Cancer Risk and Prognosis
    L'Esperance, Kevin
    Datta, Geetanjali D.
    Qureshi, Samia
    Koushik, Anita
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (04)
  • [4] Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer
    Yang, Zunxian
    Shen, Hongwei
    He, Weipeng
    Ouyang, Linlong
    Guo, Yunyun
    Qian, Fang
    Xu, Baoduan
    Xie, Dan
    Yang, Guofen
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 245 (03) : 141 - 148
  • [5] Vitamin D receptor polymorphisms in patients with cutaneous melanoma
    Orlow, Irene
    Roy, Pampa
    Reiner, Anne S.
    Yoo, Sarah
    Patel, Himali
    Paine, Susan
    Armstrong, Bruce K.
    Kricker, Anne
    Marrett, Loraine D.
    Millikan, Robert C.
    Thomas, Nancy E.
    Gruber, Stephen B.
    Anton-Culver, Hoda
    Rosso, Stefano
    Gallagher, Richard P.
    Dwyer, Terence
    Kanetsky, Peter A.
    Busam, Klaus
    From, Lynn
    Begg, Colin B.
    Berwick, Marianne
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (02) : 405 - 418
  • [6] Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis: a prospective cohort study
    Lindgren, Hampus
    Ademi, David
    Godina, Christopher
    Tryggvadottir, Helga
    Isaksson, Karolin
    Jernstroem, Helena
    CANCER CAUSES & CONTROL, 2024, 35 (06) : 907 - 919
  • [7] Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort
    Aristarco, Valentina
    Johansson, Harriet
    Gandini, Sara
    Macis, Debora
    Zanzottera, Cristina
    Tolva, Gianluca
    Feroce, Irene
    Accornero, Chiara
    Bonanni, Bernardo
    Guerrieri-Gonzaga, Aliana
    Serrano, Davide
    NUTRIENTS, 2021, 13 (04)
  • [8] Polymorphisms in the Vitamin D Receptor (VDR) and the Risk of Ovarian Cancer: A Meta-Analysis
    Liu, Yanling
    Li, Chenglin
    Chen, Peizhan
    Li, Xiaoguang
    Li, Mian
    Guo, He
    Li, Jingquan
    Chu, Ruiai
    Wang, Hui
    PLOS ONE, 2013, 8 (06):
  • [9] Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis
    Song, Gwan Gyu
    Lee, Young Ho
    IMMUNOLOGICAL INVESTIGATIONS, 2013, 42 (07) : 661 - 672
  • [10] Hormone replacement therapy and prognosis in ovarian cancer patients
    Hein, Alexander
    Thiel, Falk C.
    Bayer, Christian M.
    Fasching, Peter A.
    Haeberle, Lothar
    Lux, Michael P.
    Renner, Stefan P.
    Jud, Sebastian M.
    Schrauder, Michael G.
    Mueller, Andreas
    Wachter, David
    Strehl, Johanna
    Hartmann, Arndt
    Beckmann, Matthias W.
    Rauh, Claudia
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2013, 22 (01) : 52 - 58
12345